» Articles » PMID: 38052778

Risk of Metabolic Abnormalities in Osteoarthritis: a New Perspective to Understand Its Pathological Mechanisms

Overview
Journal Bone Res
Date 2023 Dec 5
PMID 38052778
Authors
Affiliations
Soon will be listed here.
Abstract

Although aging has traditionally been viewed as the most important risk factor for osteoarthritis (OA), an increasing amount of epidemiological evidence has highlighted the association between metabolic abnormalities and OA, particularly in younger individuals. Metabolic abnormalities, such as obesity and type II diabetes, are strongly linked to OA, and they affect both weight-bearing and non-weight-bearing joints, thus suggesting that the pathogenesis of OA is more complicated than the mechanical stress induced by overweight. This review aims to explore the recent advances in research on the relationship between metabolic abnormalities and OA risk, including the impact of abnormal glucose and lipid metabolism, the potential pathogenesis and targeted therapeutic strategies.

Citing Articles

LATS1-modulated ZBTB20 perturbing cartilage matrix homeostasis contributes to early-stage osteoarthritis.

Hao X, Zhao J, Jia L, Ding G, Liang X, Su F Bone Res. 2025; 13(1):33.

PMID: 40069162 PMC: 11897192. DOI: 10.1038/s41413-025-00414-3.


Blockade of the vaspin-AP-1 axis inhibits arthritis development.

Jeon J, Cho C, Kim S, Kim H, Lee H, Kim S Exp Mol Med. 2025; .

PMID: 40025171 DOI: 10.1038/s12276-025-01418-z.


Time-restricted feeding alleviates arthritis symptoms augmented by high-fat diet.

Bur Z, Vendl B, Sudy A, Lumniczky Z, Szanto C, Mocsai A Front Immunol. 2025; 16:1512328.

PMID: 40018036 PMC: 11864949. DOI: 10.3389/fimmu.2025.1512328.


Phospholipids and Sphingolipids in Osteoarthritis.

Steinmeyer J Biomolecules. 2025; 15(2).

PMID: 40001553 PMC: 11853253. DOI: 10.3390/biom15020250.


Deep-insights: Nanoengineered gel-based localized drug delivery for arthritis management.

Sriram A, Ithape H, Singh P Asian J Pharm Sci. 2025; 20(1):101012.

PMID: 39995751 PMC: 11848107. DOI: 10.1016/j.ajps.2024.101012.


References
1.
Thijssen E, van Caam A, van der Kraan P . Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2014; 54(4):588-600. DOI: 10.1093/rheumatology/keu464. View

2.
Koskinen A, Juslin S, Nieminen R, Moilanen T, Vuolteenaho K, Moilanen E . Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther. 2011; 13(6):R184. PMC: 3334633. DOI: 10.1186/ar3512. View

3.
Sekar S, Shafie S, Prasadam I, Crawford R, Panchal S, Brown L . Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci Rep. 2017; 7:46457. PMC: 5394476. DOI: 10.1038/srep46457. View

4.
Scuderi G . Complications after total knee arthroplasty: how to manage patients with osteolysis. J Bone Joint Surg Am. 2012; 93(22):2127-35. DOI: 10.2106/JBJS.9322icl. View

5.
Nogueira-Recalde U, Lorenzo-Gomez I, Blanco F, Loza M, Grassi D, Shirinsky V . Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine. 2019; 45:588-605. PMC: 6642320. DOI: 10.1016/j.ebiom.2019.06.049. View